Cardiac lymph flow in conscious dogs.

Area of Science:

• Cardiovascular Physiology
• Lymphatic System Research
• Surgical Methodology

Background:

• The cardiac lymphatic system plays a crucial role in maintaining cardiac homeostasis.
• Understanding cardiac lymph dynamics is essential for diagnosing and treating cardiovascular diseases.
• Previous studies were limited by anesthesia and surgical stress, hindering chronic observation.

Purpose of the Study:

• To establish a chronic canine model for studying cardiac lymphatic duct function in awake animals.
• To investigate the effects of coronary artery occlusion and reperfusion on cardiac lymph flow.
• To evaluate the impact of specific cardiovascular drugs on cardiac lymph production.

Main Methods:

• Cannulation of the cardiac lymphatic duct in dogs for chronic lymph collection (up to 3 weeks).
• Placement of an occluding device and flow probe on the circumflex coronary artery (CFX).
• Utilized ultrasonic segment length crystals to monitor left ventricular function.
• Administered cardiovascular drugs (isoproterenol, RO 2-2985, verapamil, propranolol) to assess their effects on lymph flow.

Main Results:

• Cardiac lymph flow ranged from 0.45–5.6 ml/h in control conscious dogs.
• CFX occlusion led to a significant decrease in lymph flow (up to 46%).
• Reperfusion of the CFX resulted in a substantial increase in lymph flow (up to 67%).
• Isoproterenol, RO 2-2985, and verapamil significantly increased cardiac lymph flow, while propranolol had no significant effect.

Conclusions:

• The developed chronic canine model enables long-term, stress-free study of cardiac lymphatic physiology.
• Coronary artery occlusion and reperfusion dynamically alter cardiac lymph flow.
• Specific cardiovascular drugs differentially affect cardiac lymph production, offering insights into their mechanisms.